Drug Information Portal - Mobile - U.S. National Library of Medicine - Drug Search Results

Drug Name:	Reteplase [USAN:INN:BAN]
Description:	Mutant form of tissue plasminogen activator used in treatment of myocardial infarct. Mutant form of tissue plasminogen activator used in treatment of myocardial infarct.

BM 06.022
Rapilysin
Retavase
Reteplase
UNII-DQA630RIE9

Click here for more Synonyms from ChemIDplus

2D chemical structure of 133652-38-7

Information Links

* denotes mobile formatted website
Summary
- Approved drug label from DailyMed*
- Status in ClinicalTrials.gov
Detailed Summary
Additional Resources